↓ Skip to main content

Carnitine supplementation for inborn errors of metabolism

Overview of attention for article published in Cochrane database of systematic reviews, February 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
3 tweeters

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
143 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Carnitine supplementation for inborn errors of metabolism
Published in
Cochrane database of systematic reviews, February 2012
DOI 10.1002/14651858.cd006659.pub3
Pubmed ID
Authors

Mona Nasser, Hoda Javaheri, Zbys Fedorowicz, Zaman Noorani

Abstract

Inborn errors of metabolism are genetic conditions which can lead to abnormalities in the synthesis and metabolism of proteins, carbohydrates, or fats. It has been proposed that in some instances carnitine supplementation should be provided to infants with a suspected metabolic disease as an interim measure, particularly whilst awaiting test results. Carnitine supplementation is used in the treatment of primary carnitine deficiency, and also where the deficiency is a secondary complication of several inborn errors of metabolism, such as organic acidaemias and fatty acid oxidation defects in children and adults.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 143 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Iran, Islamic Republic of 1 <1%
United Kingdom 1 <1%
Spain 1 <1%
Canada 1 <1%
Unknown 139 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 23 16%
Student > Master 22 15%
Researcher 18 13%
Student > Ph. D. Student 14 10%
Student > Doctoral Student 12 8%
Other 30 21%
Unknown 24 17%
Readers by discipline Count As %
Medicine and Dentistry 51 36%
Nursing and Health Professions 20 14%
Agricultural and Biological Sciences 8 6%
Pharmacology, Toxicology and Pharmaceutical Science 7 5%
Social Sciences 7 5%
Other 19 13%
Unknown 31 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 July 2014.
All research outputs
#8,882,382
of 14,668,766 outputs
Outputs from Cochrane database of systematic reviews
#9,174
of 11,037 outputs
Outputs of similar age
#65,918
of 121,093 outputs
Outputs of similar age from Cochrane database of systematic reviews
#98
of 125 outputs
Altmetric has tracked 14,668,766 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,037 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.5. This one is in the 15th percentile – i.e., 15% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 121,093 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 125 others from the same source and published within six weeks on either side of this one. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.